Production (Stage)
Iovance Biotherapeutics, Inc.
IOVA
$2.21
$0.167.81%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.10% | -18.54% | -3.65% | 15.82% | 27.27% |
| Total Receivables | 2.30% | 24.34% | 76.46% | 13,405.98% | 54.97% |
| Inventory | 27.22% | 33.55% | 38.50% | 58.11% | 69.85% |
| Prepaid Expenses | 28.42% | 83.53% | -33.77% | -11.35% | -34.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.17% | -8.34% | 3.38% | 25.09% | 25.23% |
|
|
|||||
| Total Current Assets | 12.17% | -8.34% | 3.38% | 25.09% | 25.23% |
| Net Property, Plant & Equipment | -1.09% | -8.36% | -0.46% | -1.76% | 3.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.05% | -7.91% | 3.84% | 0.34% | 28.37% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.13% | 1.40% | -0.72% | -0.09% | -89.97% |
| Total Assets | 6.19% | -8.14% | 2.78% | 10.86% | 11.47% |
|
|
|||||
| Total Accounts Payable | 3.56% | -13.18% | 55.20% | -20.56% | -22.41% |
| Total Accrued Expenses | 3.06% | 3.33% | 21.08% | 34.22% | -33.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -26.34% | 11.64% | 1.01% | 3.23% | 42.45% |
| Total Finance Division Other Current Liabilities | 6.97% | 228.37% | 21.67% | 1.69% | -31.84% |
| Total Other Current Liabilities | 6.97% | 228.37% | 21.67% | 1.69% | -31.84% |
| Total Current Liabilities | 0.29% | 3.63% | 26.08% | 12.53% | -24.56% |
|
|
|||||
| Total Current Liabilities | 0.29% | 3.63% | 26.08% | 12.53% | -24.56% |
| Long-Term Debt | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.33% | -33.17% | -4.13% | -4.21% | 7.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.09% | 0.31% | 1.00% | -4.22% | 91.97% |
| Total Liabilities | -0.57% | -8.10% | 11.17% | 3.15% | -3.03% |
|
|
|||||
| Common Stock & APIC | 5.37% | 1.07% | 2.43% | 6.60% | 8.12% |
| Retained Earnings | -4.87% | -3.41% | -3.76% | -4.57% | -5.61% |
| Treasury Stock & Other | 701.72% | -106.44% | 2,987.83% | 353.45% | -95.41% |
| Total Common Equity | 8.09% | -8.15% | 0.64% | 13.02% | 16.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 8.09% | -8.15% | 0.64% | 13.02% | 16.32% |
| Total Preferred Equity | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.09% | -8.15% | 0.64% | 13.02% | 16.32% |
|
|
|||||